Introduction: Macroangiopathy plays an important role, with a high prevalence of morbidity and mortality in diabetic patients. The aim was to study the epidemiological, clinical, paraclinical, therapeutic and evolutionary profile of macroangiopathy in diabetic patients in the internal medicine department of the Abass Ndao hospital. Patients and methods: This was a descriptive and analytical cross-sectional study. Our investigations were recruited over a 7-year period (January 1, 2016 to December 31, 2022). Results: Three hundred and fifty-nine (359) patients (10.22%) were enrolled. The mean age was 62.83 years, with extremes ranging from 17 to 98 years. The [60 - 69] age group was more representative (37.32%). Women accounted for 180 cases (50.1%), with a sex ratio (m/f) of 0.99. The average duration of diabetes was 11.86 years. Average consultation time was 38.07 days, with extremes ranging from 1 to 368 days. Average hospital stay was 7.65 days. Inaugural diabetes was noted in 12 cases (3.34%). Type 2 diabetes accounted for 95.82% (n = 344) of patients. Hypertension was present in 150 patients (41.8%). Patients with 2 risk factors accounted for 173 cases (48.18%). Nineteen patients had already had a stroke (5.29% of cases). Fourteen (14) patients (4.2%) were amputees. Obliterative arteriopathy of the lower limbs (AOMI) was noted in 193 patients (54%). Stroke was noted in 101 patients (28%). Ischemic heart disease (IHD) was noted in 38 patients (11%). AOMI was more common in males (110 patients, 57%) than in females (43%). Seventy-three (73) patients (20.3%) died. Predictors of death were age over 60 and the existence of more than two cardiovascular risk factors. Conclusion: Diabetic macroangiopathy is a major cause of morbidity and mortality. The development and implementation of a prevention and management program is essential.
References
[1]
Baudin, G. (2001) Le diabète sucré: De la théorie à la pratique. Médecine nucléaire (Paris), 25, 68 p.
[2]
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A.A., Ogurtsova, K., Shaw, J.E., Bright, D. and Williams, R. (2019) Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Research and Clinical Practice, 157, Article ID: 107843. https://doi.org/10.1016/j.diabres.2019.107843
[3]
Sow, D., Diédhiou, D., Diallo, I.M., Ndour, M.A., Diouf, M., Ka-Cissé, M., Sarr, A. and Ndour-Mbaye, M. (2018) Morbi Infectious Mortality of Diabetics Hospitalized at the Medical Clinic of Abass Ndao Health Center. Open Journal of Endocrine and Metabolic Diseases, 8, Article No. 1. https://doi.org/10.4236/ojemd.2018.81001
[4]
Lokrou, A. (1998) Hyperlipidémia and Diabetes in Côte d’Ivoire: A Cross-Sectional Study of 132 Cases. Médecine d’Afrique Noire, 45, 555.
[5]
Kannel, W.B. and Sorlie, P. (1979) Some Health Benefits of Physical Activity: The Framingham Study. Archives of Internal Medicine, 139, 857-861. https://doi.org/10.1001/archinte.1979.03630450011006
[6]
Mbaye, M.N., Niang, K., Sarr, A., Mbaye, A., Diedhiou, D., Ndao, M.-D., et al. (2011) Epidemiological Aspects of Diabetes in Senegal: Results of a Survey on Cardiovascular Risk Factors in the City of Saint-Louis. Medicine of Metabolic Diseases, 5, 659-664. https://doi.org/10.1016/S1957-2557(11)70343-1
[7]
Zhou, C. and Byard, R.W. (2018) An Analysis of The Morbidity and Mortality of Diabetes Mellitus in a Forensic Context. Journal of Forensic Sciences, 63, 1149-1154. https://doi.org/10.1111/1556-4029.13674
[8]
Einarson, T.R., Acs, A., Ludwig, C. and Panton, U.H. (2018) Prevalence of Cardiovascular Disease in Type 2 Diabetes: A Systematic Literature Review of Scientific Evidence from across the World in 2007-2017. Cardiovascular Diabetology, 17, Article No. 83. https://doi.org/10.1186/s12933-018-0728-6
[9]
Moran, A., Brunzell, C., Cohen, R.C., Katz, M., Marshall, B.C., Onady, G., Robinson, K.A., Sabadosa, K.A., Stecenko, A., Slovis, B. and the CFRD Guidelines Committee (2010) Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes: A Position Statement of the American Diabetes Association and a Clinical Practice Guideline of the Cystic Fibrosis Foundation, Endorsed by the Pediatric Endocrine Society. Diabetes Care, 33, 2697-2708. https://doi.org/10.2337/dc10-1768
[10]
Dioum, M., Gueye, B., Moina-Hanifa, I.I., Gaye, C., Mingou, J.S., Ngaide, A.A., Kane, A. and Diao, M. (2023) Profile of Cardiovascular Diseases of Diabetics Admitted in Fann and Dantec Cardiology Departments. Journal of Diabetes Mellitus, 13, 196-202. https://doi.org/10.4236/jdm.2023.132015
[11]
Fournet, M., Bonté, F. and Desmoulière, A. (2018) Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and Aging. Aging and Disease, 9, 880-900. https://doi.org/10.14336/AD.2017.1121
[12]
Abduelkarem, A.R., El-Shareif, H.J. and Sharif, S.I. (2010) Prognostic Indices of In-Hospital Mortality in Libyan Diabetic Patients. Practical Diabetes International, 27, 392-395. https://doi.org/10.1002/pdi.1528
[13]
Dionadji, M., Oumar, A., Nodjito, M. and Ibrahim, A. (2015) Prévalence des complications médicales chez les Diabétiques Hospitalisés à l’Hôpital Général de Référence Nationale de Ndjamena. Health Sciences and Diseases, 16, 1-4.
[14]
Charles, D., Gueye, P.M. and Wade, B. (1997) Diabetes in the Elderly: About 52 Consecutive Observations Medicine. Médecine d'Afrique Noire, 44, 21 p.
[15]
Lokrou, A. (1998) Hyerlipidémiie et diabete en Coye d’Ivoire: étude transversale de 132 cas. Médecine d’Afrique Noire, 45, 555-557.
[16]
Khanouach, H., El Gandaoui, S., Mazouzi, H., et al. (2007) Diabetic Macroangiopathy (Risk Factors). Diabetes & Metabolism, 33, 84.
[17]
Kouakou, A.Y.F., Kamagaté, A. and Yapo, A.P. (2016) Complications of Diabetes in Côte d’Ivoire among Patients Diagnosed Late. European Scientific Journal, 12, 250. https://doi.org/10.19044/esj.2016.v12n27p250
[18]
Takogue, R., Soya, E., Koffi, F., Ekou, A., Ndjessan, J.-J., Monney, E. and Konin, C. (2019) Macro-angiopathie infraclinique chez le patient diabétique traité: à propos de 420 cas colligés au service de diabétologie du CHU de Treichville (Abidajan). Journal of Vascular Medicine, 44, 155. https://doi.org/10.1016/j.jdmv.2018.12.146
[19]
Sebai, I., Oueslati, I., Khessairi, N., Yazidi, M., Talbi, E., Chaker, F. and Chihaoui, M. (2019) Predictive Factors of Macroangiopathy in Type 2 Diabetic Patients. Archives of Cardiovascular Diseases Supplements, 11, e337. https://doi.org/10.1016/j.acvdsp.2019.05.015
[20]
Huxley, R., Barzi, F. and Woodward, M. (2006) Excess Risk of Fatal Coronary Heart Disease Associated with Diabetes in Men and Women: Meta-Analysis of 37 Prospective Cohort Studies. BMJ, 332, 73-78. https://doi.org/10.1136/bmj.38678.389583.7C
[21]
Cederholm, J., Eeg-Olofsson, K., Eliasson, B., Zethelius, B., Nilsson, P.M. and Gudbjörnsdottir, S. (2008) Risk Prediction of Cardiovascular Disease in Type 2 Diabetes: A Risk Equation from the Swedish National Diabetes Register. Diabetes Care, 31, 2038-2043. https://doi.org/10.2337/dc08-0662
[22]
Sow, D., Diedhiou, D., Diallo, I.M., Ndour, M.A., Ndiaye, A., Cissé, M.K., et al. (2018) Study of Cardiovascular Risk Factors in Type 2 Diabetic Patients at the Marc Sankalé Center in Dakar. African Journal of Internal Medicine, 5, 43-49.
[23]
Nemi, K.D., Djalogue, L., Djagadou, K.A., Tchamdja, T., Tsevi, Y.M. and Balaka, A. (2019) Les modes de révélation du diabète sucré au CHU Sylvanus Olympio de Lomé. The Pan African Medical Journal, 34, Article No. 99. https://doi.org/10.11604/pamj.2019.34.99.20012
[24]
Ouédraogo, M., Ouédraogo, S.M., Barba, E. and Drabo, Y.J. (2000) Acute Complications of Diabetes Mellitus at the Centre Hospitalier National Yalgado Ouedraogo. Médecine d’Afrique Noire, 47, 505-507.
[25]
Djibril, M.A., Balaka, A., Nemi, K.D., Tchamdja, T. and Agbetra, A. (2013) Diabetic Emergencies in Lomé: Epidemiological and Prognostic Aspects. Journal de la Recherche Scientifique de l’Université de Lomé, 15, 353-358.
[26]
Yessoufou, A.G., Behanzin, J., Djihoumeto, E., Isstina, A., Ahokpe, M. and Sezan, A. (s.d.) Epidemiological Aspects of Metabolic Syndrome in the Obese Population of Commune Ouidah in Southwest Benin.
[27]
Brehima, B. (2009) Study of the Prevalence of Metabolic Syndrome in the Diabetic Population of Bamako and the Influence of Diet and Physical Activity in the Management of These Patients. Medicine Thesis, University of Bamako, Bamako, 79.
[28]
Mitsios, J.P., Ekinci, E.I., Mitsios, G.P., Churilov, L. and Thijs, V. (2018) Relationship between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta-Analysis. Journal of the American Heart Association, 7, e007858. https://doi.org/10.1161/JAHA.117.007858
[29]
Kengne, A.P. and Echouffo-Tcheugui, J.B. (2011) Utility of Models for Estimating Cardiovascular Risk in People with Diabetes. Sang Thrombose Vaisseaux, 23, 292-298.
[30]
Ragul, B., Kiran, P.K. and Gupta, A.K. (2019) Screening of Type 2 Diabetes Mellitus Patients for Their Macrovascular Complications in Tertiary Care Hospital. International Journal of Advances in Medicine, 6, 1388-1392.
[31]
Rawshani, A., et al. (2018) Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine, 379, 633-644.
[32]
Belhadj, M., Malek, R., Boudiba, A., et al. (2010) DiabCare Algérie. Médecine des Maladies Métaboliques, 4, 88-92. https://doi.org/10.1016/S1957-2557(10)70020-1
[33]
Ndambwe, M.V., Jemea, B., Bayiha, J.E., Epacka, E.M. and Ngo, N.B. (2021) Prevalence of Obliterative Arteriopathy of the Lower Limbs in Diabetic Patients at the Douala General Hospital Prevalence of Peripheral Vascular Disease of the Lower Limbs in Diabetic Patients at the Douala General Hospital. Health Sciences and Disease, 22, 29-34.
